[A case of MCTD patient with recurrent hemoperitoneum receiving CAPD who had a successful recovery with an increase in steroids].
A-48-year-old man with end stage renal disease due to MCTD started CAPD in February 1988. He also had been treated by steroid therapy which was gradually decreased. He had seven hemoperitoneum episodes for ten months and two years since starting CARD. None of episodes were associated with CAPD catheter nor bacillus peritonitis. While he had had long term hemoperitoneum episode in March 1989, he was received no steroid and had leucopenia and low compliments. Therefore he was treated by steroids again. He had no hemoperitoneum episodes for seventeen months since re-steroid therapy. And he recovered from leucopenia and low compliments. It seems that the mechanisms of hemoperitoneum are due to immunological abnormality associated with MCTD.
Ohtomo
Y
Y
Kidney Center, Wakayama Red Cross Hospital.
Higasi
Y
Y
D006465:Hemoperitoneum / Q000209:etiology*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D008947:Mixed Connective Tissue Disease / Q000150:complications* / Q000188:drug therapy; D010531:Peritoneal Dialysis, Continuous Ambulatory; D012008:Recurrence
D008775:Methylprednisolone